113 related articles for article (PubMed ID: 28851592)
1. Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors.
O'Donnell E; Markt SC; Miller R; Bernard B; Albiges L; Beard C; Sweeney C
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28851592
[TBL] [Abstract][Full Text] [Related]
2. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
3. Body Mass Index and Outcomes in Germ-Cell Tumors.
McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium.
Shaikh F; Stark D; Fonseca A; Dang H; Xia C; Krailo M; Pashankar F; Rodriguez-Galindo C; Olson TA; Nicholson JC; Murray MJ; Amatruda JF; Billmire D; Stoneham S; Frazier AL
Cancer; 2021 Jan; 127(2):193-202. PubMed ID: 33079404
[TBL] [Abstract][Full Text] [Related]
5. Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer.
Wang X; Ricciuti B; Alessi JV; Nguyen T; Awad MM; Lin X; Johnson BE; Christiani DC
J Natl Cancer Inst; 2021 Nov; 113(12):1761-1769. PubMed ID: 34115098
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C
Ann Oncol; 2016 May; 27(5):875-9. PubMed ID: 26861605
[TBL] [Abstract][Full Text] [Related]
7. Cigarette Smoking and Pancreatic Cancer Survival.
Yuan C; Morales-Oyarvide V; Babic A; Clish CB; Kraft P; Bao Y; Qian ZR; Rubinson DA; Ng K; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
J Clin Oncol; 2017 Jun; 35(16):1822-1828. PubMed ID: 28358654
[TBL] [Abstract][Full Text] [Related]
8. Smoking and prostate cancer survival and recurrence.
Kenfield SA; Stampfer MJ; Chan JM; Giovannucci E
JAMA; 2011 Jun; 305(24):2548-55. PubMed ID: 21693743
[TBL] [Abstract][Full Text] [Related]
9. Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.
Williams LA; Frazier AL; Poynter JN
Int J Cancer; 2020 May; 146(9):2433-2441. PubMed ID: 31304572
[TBL] [Abstract][Full Text] [Related]
10. Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.
Gariscsak PJ; Anson-Cartwright L; Atenafu EG; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Glicksman RM; Hamilton RJ
Eur Urol Open Sci; 2022 Jun; 40():46-53. PubMed ID: 35638085
[TBL] [Abstract][Full Text] [Related]
11. Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy.
Caso R; Jones GD; Tan KS; Bosl GJ; Funt SA; Sheinfeld J; Reuter VE; Amar D; Fischer G; Molena D; Rocco G; Bains MS; Feldman DR; Jones DR
Ann Thorac Surg; 2021 Apr; 111(4):1141-1149. PubMed ID: 32882201
[TBL] [Abstract][Full Text] [Related]
12. Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation.
Almutairi F; Geisler D; Rammal R; Korentzelos D; Bastacky S; Dhir R; Bhattu A; Quiroga-Garza GM
Ann Diagn Pathol; 2023 Feb; 62():152070. PubMed ID: 36495736
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical characteristics, treatment patterns, and outcome of patients with bilateral testicular germ cell tumors.
Azik H; Omri N; Kamil M; Miki H; Shay G; Roy M; Yuval F; Barak R; Ben S; Yariv S; Reuven BD; Gilad AE
Discov Oncol; 2024 Feb; 15(1):30. PubMed ID: 38321336
[TBL] [Abstract][Full Text] [Related]
14. The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.
Nayan M; Jewett MA; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Sweet J; O'Malley M; Hamilton RJ
Can Urol Assoc J; 2016; 10(5-6):204-209. PubMed ID: 27713801
[TBL] [Abstract][Full Text] [Related]
15. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study.
Amini A; Waxweiler TV; Maroni PD; Kessler ER; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
J Pediatr Urol; 2016 Dec; 12(6):405.e1-405.e9. PubMed ID: 27544905
[TBL] [Abstract][Full Text] [Related]
16. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
17. DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients.
Sestakova Z; Kalavska K; Smolkova B; Miskovska V; Rejlekova K; Sycova-Mila Z; Palacka P; Obertova J; Holickova A; Hurbanova L; Jurkovicova D; Roska J; Goffa E; Svetlovska D; Chovanec M; Mardiak J; Mego M; Chovanec M
Mutat Res Genet Toxicol Environ Mutagen; 2020; 854-855():503200. PubMed ID: 32660824
[TBL] [Abstract][Full Text] [Related]
18. Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation.
Mayadev J; Lim J; Durbin-Johnson B; Valicenti R; Alvarez E
Am J Clin Oncol; 2018 Mar; 41(3):295-301. PubMed ID: 26808259
[TBL] [Abstract][Full Text] [Related]
19. Association Between Head and Neck Squamous Cell Carcinoma Survival, Smoking at Diagnosis, and Marital Status.
Osazuwa-Peters N; Adjei Boakye E; Chen BY; Tobo BB; Varvares MA
JAMA Otolaryngol Head Neck Surg; 2018 Jan; 144(1):43-50. PubMed ID: 29121146
[TBL] [Abstract][Full Text] [Related]
20. Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.
Raggi D; Mariani L; Giannatempo P; Lo Vullo S; Giardiello D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Calareso G; Magni M; Di Nicola M; Verzoni E; Grassi P; Procopio G; De Braud F; Pizzocaro G; Salvioni R; Necchi A
Urol Oncol; 2015 Jul; 33(7):332.e19-24. PubMed ID: 25985712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
